Camptodactyly-arthropathy-coxa vara-pericarditis syndrome
| Camptodactyly-arthropathy-coxa vara-pericarditis syndrome | |
|---|---|
| Synonyms | CACP syndrome |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Camptodactyly, Arthropathy, Coxa vara, Pericarditis |
| Complications | N/A |
| Onset | Childhood |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation in the PRG4 gene |
| Risks | Family history |
| Diagnosis | Clinical examination, Genetic testing |
| Differential diagnosis | Juvenile idiopathic arthritis, Rheumatoid arthritis |
| Prevention | N/A |
| Treatment | Physical therapy, Surgical intervention |
| Medication | N/A |
| Prognosis | Variable, depends on severity |
| Frequency | Rare |
| Deaths | N/A |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome (CACP) is a rare genetic disorder characterized by a combination of physical abnormalities and symptoms. The syndrome was first described in the medical literature in 1982 by Dr. Jacques Drenth and Dr. John Winchester, who identified the condition in a family of Middle Eastern descent.
Symptoms and Characteristics[edit]
The primary characteristics of CACP syndrome include camptodactyly, arthropathy, coxa vara, and pericarditis.
- Camptodactyly refers to a medical condition where the fingers are permanently bent. In the case of CACP syndrome, this typically affects the little fingers and can be present from birth.
- Arthropathy is a general term for any disease of the joints. In CACP syndrome, this often presents as non-inflammatory joint disease, leading to joint deformities and limitations in movement.
- Coxa vara is a deformity of the hip, where the angle between the head and the shaft of the femur is reduced, causing a decrease in the angle between the hip and the knee. This can lead to a noticeable limp and reduced mobility.
- Pericarditis is inflammation of the pericardium, the sac-like covering around the heart. This can cause chest pain and other symptoms related to heart function.
Causes[edit]
CACP syndrome is caused by mutations in the PRG4 gene. This gene provides instructions for making a protein called lubricin, which is found in joint fluid and on the surface of cartilage, and helps to reduce friction between the bones in a joint during movement.
Diagnosis and Treatment[edit]
Diagnosis of CACP syndrome is based on the presence of the characteristic signs and symptoms. Genetic testing can confirm a diagnosis by identifying a mutation in the PRG4 gene. There is currently no cure for CACP syndrome. Treatment is focused on managing the symptoms and improving quality of life. This may include physical therapy, pain management, and in some cases, surgery to correct joint deformities.
See Also[edit]
References[edit]
| Genetic disorders relating to deficiencies of transcription factor or coregulators | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NIH genetic and rare disease info[edit]
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Camptodactyly-arthropathy-coxa vara-pericarditis syndrome
|
| Joint diseases | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This joint diseases related article is a stub.
|
| Cardiovascular disease (heart) | ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
